A look at the shareholders of Gerresheimer AG (ETR:GXI) can tell us which group is most powerful. We can see that institutions own the lion's share in the company with 77% ownership. That is, the ...

Gerresheimer AG's (ETR:GXI) recent weak earnings report didn't cause a big stock movement. However, we believe that investors should be aware of some underlying factors which may be of concern.

Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, has successfully completed an expansion and modernization project at ...

A group comprising private equity companies Warburg Pincus and KKR is reportedly in discussions to acquire Gerresheimer, a German company specialising in packaging for medicines and beauty products.

In a report released today, Delphine Le Louet from Bernstein maintained a Buy rating on Gerresheimer (0NTI – Research Report), with a price target of €85.10. The company’s shares closed ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

UBS analyst Olivier Calvet maintained a Buy rating on Gerresheimer (0NTI – Research Report) today and set a price target of €97.00. The company’s shares closed yesterday at €52.15.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...